Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Nov;35(11):1632–1636. doi: 10.1136/gut.35.11.1632

Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth.

W J Adams 1, J A Lawson 1, D L Morris 1
PMCID: PMC1375627  PMID: 7828988

Abstract

The effect of histamine and cimetidine on the growth of four human colon cancer cell lines was studied. Histamine significantly stimulated the uptake of tritiated thymidine in vitro in a dose dependent manner, to a maximum of 120% and 116% of controls for C170 and LIM2412, respectively. This effect was antagonised by cimetidine, but not diphenhydramine. Histamine also stimulated a dose dependent increase in cyclic adenosine monophosphate accumulation in C170 cells, antagonised by cimetidine. When grown as subcutaneous xenografts in Balb/c nu/nu mice, cimetidine had a significant inhibitory effect on the same two cell lines. The final volume of C170 tumours in animals given cimetidine was 44% of controls. This response was dose dependent, plateauing at a cimetidine dose of 50 mg/kg/day. The final volume of LIM2412 tumours in animals given cimetidine was 60% of controls. Histamine administered locally by a mini-osmotic pump stimulated C170 tumour growth to 164% of controls, was antagonised by cimetidine at a dose of 200 mg/kg/day, but not by lower concentrations. Histamine has a trophic effect on at least two colorectal cancer cell lines in vivo and in vitro. As this effect is antagonised by cimetidine, it may be mediated via tumour histamine type 2 receptors.

Full text

PDF
1632

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams W. J., Lawson J. A., Nicholson S. E., Cook T. A., Morris D. L. The growth of carcinogen-induced colon cancer in rats is inhibited by cimetidine. Eur J Surg Oncol. 1993 Aug;19(4):332–335. [PubMed] [Google Scholar]
  2. Armitage J. O., Sidner R. D. Antitumour effect of cimetidine. Lancet. 1979 Apr 21;1(8121):882–883. doi: 10.1016/s0140-6736(79)91306-0. [DOI] [PubMed] [Google Scholar]
  3. Bartholeyns J., Bouclier M. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res. 1984 Feb;44(2):639–645. [PubMed] [Google Scholar]
  4. Drewinko B., Romsdahl M. M., Yang L. Y., Ahearn M. J., Trujillo J. M. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res. 1976 Feb;36(2 Pt 1):467–475. [PubMed] [Google Scholar]
  5. Durrant L. G., Robins R. A., Pimm M. V., Perkins A. C., Armitage N. C., Hardcastle J. D., Baldwin R. W. Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer. 1986 Jan;53(1):37–45. doi: 10.1038/bjc.1986.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Emami S., Gespach C., Bodéré H. Selective disappearance of histamine H2-receptor activity in the human gastric cancer cell line HGT-1 after short-term or chronic treatment by histamine or its H2-antagonists. Agents Actions. 1985 Apr;16(3-4):195–198. doi: 10.1007/BF01983137. [DOI] [PubMed] [Google Scholar]
  7. Euhus D. M., Hudd C., LaRegina M. C., Johnson F. E. Tumor measurement in the nude mouse. J Surg Oncol. 1986 Apr;31(4):229–234. doi: 10.1002/jso.2930310402. [DOI] [PubMed] [Google Scholar]
  8. Fisher E. R., Paik S. M., Rockette H., Jones J., Caplan R., Fisher B. Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). Hum Pathol. 1989 Feb;20(2):159–163. doi: 10.1016/0046-8177(89)90180-9. [DOI] [PubMed] [Google Scholar]
  9. Gifford R. R., Ferguson R. M., Voss B. V. Cimetidine reduction of tumour formation in mice. Lancet. 1981 Mar 21;1(8221):638–640. doi: 10.1016/s0140-6736(81)91555-5. [DOI] [PubMed] [Google Scholar]
  10. Gifford R. R., Tilberg A. F. Histamine type-2 receptor antagonist immune modulation. II. Cimetidine and ranitidine increase interleukin-2 production. Surgery. 1987 Aug;102(2):242–247. [PubMed] [Google Scholar]
  11. Griswold D. E., Alessi S., Badger A. M., Poste G., Hanna N. Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J Immunol. 1984 Jun;132(6):3054–3057. [PubMed] [Google Scholar]
  12. Hill S. J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev. 1990 Mar;42(1):45–83. [PubMed] [Google Scholar]
  13. Khan M. M., Keaney K. M., Melmon K. L., Clayberger C., Krensky A. M. Histamine regulates the generation of human cytolytic T lymphocytes. Cell Immunol. 1989 Jun;121(1):60–73. doi: 10.1016/0008-8749(89)90005-1. [DOI] [PubMed] [Google Scholar]
  14. Kikuchi Y., Oomori K., Kizawa I., Kato K. Effects of cimetidine on tumor growth and immune function in nude mice bearing human ovarian carcinoma. J Natl Cancer Inst. 1985 Feb;74(2):495–498. [PubMed] [Google Scholar]
  15. Kumar A., Cleveland R. P. "Immunoregulatory effects of cimetidine: inhibition of suppressor cell effector function in vivo". Immunopharmacol Immunotoxicol. 1988;10(3):327–332. doi: 10.3109/08923978809041424. [DOI] [PubMed] [Google Scholar]
  16. Kusyk C. J., McNiel N. O., Johnson L. R. Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol. 1986 Nov;251(5 Pt 1):G597–G601. doi: 10.1152/ajpgi.1986.251.5.G597. [DOI] [PubMed] [Google Scholar]
  17. Laboisse C. L., Augeron C., Couturier-Turpin M. H., Gespach C., Cheret A. M., Potet F. Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors. Cancer Res. 1982 Apr;42(4):1541–1548. [PubMed] [Google Scholar]
  18. Osband M. E., Hamilton D., Shen Y. J., Cohen E., Shlesinger M., Lavin P., Brown A., McCaffrey R. Successful tumour immunotherapy with cimetidine in mice. Lancet. 1981 Mar 21;1(8221):636–638. doi: 10.1016/s0140-6736(81)91554-3. [DOI] [PubMed] [Google Scholar]
  20. Shibata M., Hoon D., Okun E., Morton D. Modulation of histamine type II receptors on CD8+ T cells by interleukin-2 and cimetidine. Int Arch Allergy Immunol. 1992;97(1):8–16. doi: 10.1159/000236089. [DOI] [PubMed] [Google Scholar]
  21. Tutton P. J., Steel G. G. Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br J Cancer. 1979 Nov;40(5):743–749. doi: 10.1038/bjc.1979.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tønnesen H., Knigge U., Bülow S., Damm P., Fischerman K., Hesselfeldt P., Hjortrup A., Pedersen I. K., Pedersen V. M., Siemssen O. J. Effect of cimetidine on survival after gastric cancer. Lancet. 1988 Oct 29;2(8618):990–992. doi: 10.1016/s0140-6736(88)90743-x. [DOI] [PubMed] [Google Scholar]
  23. Watson S. A., Wilkinson L. J., Robertson J. F., Hardcastle J. D. Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut. 1993 Aug;34(8):1091–1096. doi: 10.1136/gut.34.8.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Whitehead R. H., Zhang H. H., Hayward I. P. Retention of tissue-specific phenotype in a panel of colon carcinoma cell lines: relationship to clinical correlates. Immunol Cell Biol. 1992 Aug;70(Pt 4):227–236. doi: 10.1038/icb.1992.30. [DOI] [PubMed] [Google Scholar]
  25. Whitehead R. J., Taylor D. J., Evanson J. M., Hart I. R., Woolley D. E. Demonstration of histamine H2 receptors on human melanoma cells. Biochem Biophys Res Commun. 1988 Feb 29;151(1):518–523. doi: 10.1016/0006-291x(88)90624-9. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES